It’s unclear if Great Britain’s exit from the European Union will slow down or derail the progress made by the U.S. to establish a synchronized and more timely biotech approval process in Europe. Nebraska farmer and U.S. Soybean Export Council Director Jim Miller was in Europe during the Brexit vote meeting with EU government officials on market access issues. He says they spoke about the reauthorization of glyphosate, which was actually granted this week.
He says the reauthorization of glyphosate may actually be the catalyst to move the remaining U.S. biotech traits awaiting EU approval.
Miller says despite that they pushed members of the European Parliament to get a more timely and orderly biotech approval process put in place.
Miller says they were hoping to use the TTIP negotiations to also get the EU to establish a synchronized biotech approval process with the U.S., but it’s unclear if that will be possible after Brexit.
